Mirati Financial Statements From 2010 to 2024
| MRTXDelisted Stock | USD 58.70 0.00 0.00% |
Check Mirati Ther financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mirati main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Mirati financial statements analysis is a perfect complement when working with Mirati Ther Valuation or Volatility modules.
Mirati |
Mirati Ther Company Return On Asset Analysis
Mirati Ther's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Mirati Ther Return On Asset | -0.39 |
Most of Mirati Ther's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mirati Ther is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Mirati Ther has a Return On Asset of -0.393. This is 95.51% lower than that of the Biotechnology sector and 98.33% lower than that of the Health Care industry. The return on asset for all United States stocks is 180.71% higher than that of the company.
Mirati Ther Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Mirati Ther's current stock value. Our valuation model uses many indicators to compare Mirati Ther value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mirati Ther competition to find correlations between indicators driving Mirati Ther's intrinsic value. More Info.Mirati Ther is rated below average in return on equity category among related companies. It is rated below average in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Mirati Ther by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Mirati Ther's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Mirati Ther's earnings, one of the primary drivers of an investment's value.About Mirati Ther Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Mirati Ther income statement, its balance sheet, and the statement of cash flows. Mirati Ther investors use historical funamental indicators, such as Mirati Ther's revenue or net income, to determine how well the company is positioned to perform in the future. Although Mirati Ther investors may use each financial statement separately, they are all related. The changes in Mirati Ther's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Mirati Ther's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Mirati Ther Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Mirati Ther. Please read more on our technical analysis and fundamental analysis pages.
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. Mirati Therapeutics, Inc. was founded in 1995 and is headquartered in San Diego, California. Mirati Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 413 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Consideration for investing in Mirati Stock
If you are still planning to invest in Mirati Ther check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mirati Ther's history and understand the potential risks before investing.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |